Duarte-Dorado Diana M, Madero-Orostegui Danitza S, Rodriguez-Martinez Carlos E, Nino Gustavo
Department of Pediatric Pulmonology, Fundación Valle de Lili , Cali , Colombia .
J Asthma. 2013 Dec;50(10):1056-61. doi: 10.3109/02770903.2013.834504. Epub 2013 Sep 19.
Although assessment of the severity of bronchiolitis using severity scores is important both in daily practice and as an outcome measure in clinical trials, many of these scores have not been formally validated or have been only partially validated.
We conducted a prospective cohort study on a sample of children diagnosed with bronchiolitis. Two physicians independently assessed all of the children on the modified Wood's Clinical Asthma Score (M-WCAS) and on the Tal et al. severity score and collected the information required to assess the criterion validity, construct validity, inter-rater agreement, sensitivity to change, and usability of the M-WCAS.
The median (interquartilic range [IQR]) of the age of the 54 patients included in the study was 5 (2-9) months. Thirty (55.6%) of the patients were males and 24 (44.4%) were female. The scores of the M-WCAS correlated positively with the scores of the Tal et al. severity score (ρ = 0.761, p < 0.001). The scores of the M-WCAS in patients who required subsequent admission to the PICU were significantly higher than those in patients who required admission only to the pediatric medical floor (PMF) [4.5 (3.6-5.2) vs. 2.5 (1.5-2.5), p < 0.001]. The inter-rater agreement for the raters was found to be κ = 0.897 (p < 0.001), 95% CI (0.699-1.000). The scores of the M-WCAS in patients at admission to the PMF were significantly higher than those obtained immediately before discharge from the hospital [2.5 (1.9-2.5) vs. 1.0 (0.5-1.6), p < 0.001).
Our results suggest that the M-WCAS severity score has adequate criterion validity, adequate construct validity, adequate inter-rater agreement, adequate sensitivity to change, and appropriate usability for infants hospitalized for acute bronchiolitis.
尽管在日常实践以及临床试验中作为一项结果指标,使用严重程度评分来评估细支气管炎的严重程度很重要,但其中许多评分尚未得到正式验证,或者仅得到部分验证。
我们对一组被诊断为细支气管炎的儿童样本进行了一项前瞻性队列研究。两名医生独立地根据改良的伍德临床哮喘评分(M-WCAS)和塔尔等人的严重程度评分对所有儿童进行评估,并收集评估M-WCAS的标准效度、结构效度、评分者间一致性、对变化的敏感性和可用性所需的信息。
纳入研究的54例患者的年龄中位数(四分位间距[IQR])为5(2-9)个月。30例(55.6%)患者为男性,24例(44.4%)为女性。M-WCAS评分与塔尔等人的严重程度评分呈正相关(ρ = 0.761,p < 0.001)。需要随后入住儿科重症监护病房(PICU)的患者的M-WCAS评分显著高于仅需入住儿科普通病房(PMF)的患者[4.5(3.6-5.2)对2.5(1.5-2.5),p < 0.001]。评分者间的一致性为κ = 0.897(p < 0.001),95%置信区间(0.699-1.000)。入住PMF的患者入院时的M-WCAS评分显著高于出院前即刻获得的评分[2.5(1.9-2.5)对1.0(0.5-1.6),p < 0.001]。
我们的结果表明,M-WCAS严重程度评分对于因急性细支气管炎住院的婴儿具有足够的标准效度、足够的结构效度、足够的评分者间一致性、足够的对变化的敏感性以及适当的可用性。